Cullinan Therapeutics (CGEM) Shares Repurchased (2020)

Historic Shares Repurchased for Cullinan Therapeutics (CGEM) over the last 1 years, with Q4 2020 value amounting to $6.4 million.

  • Cullinan Therapeutics' Shares Repurchased changed N/A to $6.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $6.6 million, marking a year-over-year change of. This contributed to the annual value of $6.6 million for FY2020, which is N/A changed from last year.
  • As of Q4 2020, Cullinan Therapeutics' Shares Repurchased stood at $6.4 million.
  • Cullinan Therapeutics' 5-year Shares Repurchased high stood at $6.4 million for Q4 2020, and its period low was $213000.0 during Q1 2020.